Please use this identifier to cite or link to this item: http://nopr.niscpr.res.in/handle/123456789/9993
Full metadata record
DC FieldValueLanguage
dc.contributor.authorVohora, Divya-
dc.contributor.authorKhanam, Razia-
dc.contributor.authorPal, Shanthi N-
dc.contributor.authorPillai, K K-
dc.date.accessioned2010-07-19T08:27:49Z-
dc.date.available2010-07-19T08:27:49Z-
dc.date.issued2010-08-
dc.identifier.issn0975-1009 (Online); 0019-5189 (Print)-
dc.identifier.urihttp://hdl.handle.net/123456789/9993-
dc.description858-860en_US
dc.description.abstractMethionine-sulfoximine (MSO), a convulsant is known to increase the activity of histamine N-methyl transferase. The effect of a selective H3 receptor agonist R- ( ) methylhistamine (RAMH) and antagonist (thioperamide, THP) and some antiepileptic drugs (gabapentin and sodium valproate) have been evaluated on MSO-induced convulsions in mice. The effect of THP was also evaluated in combination with these antiepileptic drugs. Sodium valproate (300 mg/kg, po) and gabapentin (400 mg/kg, po) offered protection against MSO-induced convulsions as evidenced by a significant prolongation of latency to abnormal dorsoflexion and complete protection against mortality within 6 h of administration. THP (15 mg/kg, ip) alone and in combination with sub-effective doses of gabapentin (75 mg/kg, po) and sodium valproate (75 mg/kg, po) revealed no significant differences from the control group or either drug alone. Hence, the convulsant action of MSO does not appear to be mediated via histaminergic mechanisms.en_US
dc.language.isoen_USen_US
dc.publisherCSIRen_US
dc.sourceIJEB Vol.48(08) [August 2010]en_US
dc.subjectGabapentinen_US
dc.subjectMethionine-sulfoximineen_US
dc.subjectSodium valproateen_US
dc.subjectThioperamideen_US
dc.titleEffect of combined treatment of thioperamide with some antiepileptic drugs on methionine-sulfoximine induced convulsions in miceen_US
dc.typeArticleen_US
Appears in Collections:IJEB Vol.48(08) [August 2010]

Files in This Item:
File Description SizeFormat 
IJEB 48(8) 858-860.pdf59.25 kBAdobe PDFView/Open


Items in NOPR are protected by copyright, with all rights reserved, unless otherwise indicated.